MEIRAJ F ZUBERI
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MORRIS, IL NPI 1497958201
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism IL Abbott Laboratories All categories
General Payments — all program years on this page
$33,834.23
- Category: General Payments
- Program years: PY2018–2024
- Record count: 771
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $5,405.23 across 80 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,457.58 | 75 |
| Consulting Fee | $1,837.50 | 1 |
| Travel and Lodging | $1,098.86 | 3 |
| Education | $11.29 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $2,246.13 | 11 |
| Medtronic, Inc. | $1,374.11 | 9 |
| Insulet Corporation | $472.19 | 8 |
| Novo Nordisk AS | $284.20 | 10 |
| Corcept Therapeutics | $178.09 | 7 |
| Xeris Pharmaceuticals, Inc. | $102.01 | 5 |
| Radius Health, Inc. | $85.48 | 4 |
| BETA BIONICS, INC. | $85.15 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $81.57 | 4 |
| CeQur Corporation | $72.93 | 1 |
| Acerta Pharma LLC | $57.10 | 1 |
| Antares Pharma, Inc. | $49.20 | 2 |
| BAXTER HEALTHCARE | $45.70 | 2 |
| Neurocrine BioSciences, Inc. | $34.30 | 1 |
| Amgen Inc. | $34.07 | 2 |
| Lilly USA, LLC | $32.69 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.65 | 2 |
| Amneal Pharmaceuticals LLC | $25.58 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.55 | 1 |
| Mallinckrodt Hospital Products Inc. | $22.45 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.16 | 1 |
| Axsome Therapeutics, Inc. | $19.17 | 1 |
| ANI Pharmaceuticals, Inc. | $15.83 | 1 |
| Ascendis Pharma Inc | $14.92 | 1 |
By program year
Records — PY2024 (80)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.